Usefulness of the Early Increase of Peripheral Blood Lymphocyte Count in Predicting Clinical Outcomes for Patients with Advanced Hepatocellular Carcinoma Treated with Durvalumab Plus Tremelimumab
In Dur/Tre therapy, the early increase in peripheral blood lymphocyte count was useful for predicting clinical response and prognosis.
Authors
- Masatoshi Ikemi
- Yuichi Honma (ORCID: https://orcid.org/0000-0001-7112-3479)
- Michihiko Shibata
- Shinji Oe (ORCID: https://orcid.org/0000-0002-9623-3663)
- Noriyoshi Ogino (ORCID: https://orcid.org/0000-0002-1877-7577)
- Koichiro Miyagawa
- Masaru Harada (ORCID: https://orcid.org/0000-0001-9891-3526)
- Nobuhiko Shinohara
- Shintaro Abe
- Kengo Yoshitomi (ORCID: https://orcid.org/0000-0002-7463-0158)
Institutions
- University of Occupational and Environmental Health Japan (JP)
Publication Details
- Journal
- Cancers
- Published
- 2025-04-09
- DOI
- https://doi.org/10.3390/cancers17081274
- Citations
- 1
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.32